New hope for sickle cell pain: drug trial aims to cut opioid use
NCT ID NCT07498309
Summary
This study is testing whether a drug called iloprost can help adults with sickle cell disease during painful vaso-occlusive crises. Researchers will give 144 hospitalized patients either iloprost or a placebo through an IV to see if it reduces their pain and how much opioid pain medication they need. The main goal is to see if iloprost helps people get through these painful episodes with less strong pain medicine.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
CHU de Rouen
Rouen, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.